{
  "meta": {
    "title": "Obgyn_Rdx_Quiz",
    "url": "https://brainandscalpel.vercel.app/obgyn-rdx-quiz-28993959.html",
    "scrapedAt": "2025-11-30T08:53:02.715Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Emergency myomectomy</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetaminophen and bed rest</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Intravenous broad-spectrum antibiotics</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Elective cesarean section at 32 weeks</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old woman at 32 weeks gestation presents with severe pelvic pain, low-grade fever, and localized tenderness over a known 6 cm uterine fibroid. Ultrasound reveals a heterogeneous fibroid with areas of hemorrhage. Laboratory findings include mild leukocytosis and normal C-reactive protein. What is the most appropriate initial management for this patient?</span></p>",
      "unique_key": "Q324428",
      "question_audio": null,
      "question_video": null,
      "map_id": 324428,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation</strong>:</p><p>The patient has <strong>red degeneration of fibroid</strong> in pregnancy, which presents with acute pain, mild fever, and localized tenderness. The appropriate management is <strong>a</strong><strong>cetaminophen and bed rest</strong>, as the condition is self-limiting and usually resolves without surgical intervention.</p><p><strong>Acetaminophen (paracetamol)</strong> is the preferred first-line analgesic at and beyond 32 weeks gestation, as NSAIDs carry risk of premature closure of the fetal ductus arteriosus and oligohydramnios if used during the third trimester.</p><p><strong>Effect of pregnancy on fibroids</strong></p><ul><li>Fibroids generally increase in size during pregnancy.</li><li>Vascularity increases.</li><li>Higher tendency for degenerative changes:<ul><li>Hyaline change</li><li>Cystic degeneration</li></ul></li></ul><p><strong>Red degeneration (carneous degeneration)</strong></p><ul><li>Caused by rupture of capillaries &rarr; blood effuses into myoma.</li><li>Leads to diffuse reddish discoloration.</li><li><strong>Clinical features:</strong><ul><li>Severe abdominal pain (acute abdomen presentation)</li><li>Pain localized to uterus around fibroid</li><li>Vital parameters remain stable</li></ul></li><li><strong>Management:</strong> Conservative &rarr; bed rest + analgesics.</li><li><strong>Laparotomy findings (rare cases):</strong><ul><li>Fibroid appears dusky.</li><li>Cut section looks like <strong>beefy red/ cooked meat appearance</strong>.</li></ul></li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Emergency myomectomy (Option A):</strong> Not routinely indicated during pregnancy because it carries a high risk of severe hemorrhage, uterine rupture, and fetal loss. It is reserved only for intractable pain unresponsive to medical management, or when red degeneration mimics an acute abdomen with diagnostic uncertainty (e.g., cannot rule out appendicitis or torsion).</p><p><strong>Intravenous broad-spectrum antibiotics (Option C):</strong> No evidence of infection (normal CRP, no systemic features); antibiotics are unnecessary.</p><p><strong>Elective cesarean section at 32 weeks (Option D):</strong> Not indicated; exposes fetus to prematurity. Delivery is only considered if obstetric indications arise later.</p><p><strong>Key Takeaway:</strong></p><ul><li><strong>Red degeneration of fibroid in pregnancy</strong> is treated <strong>conservatively with analgesia and bed rest</strong>, not surgery or antibiotics.</li></ul>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">1A, 2B, 3C, 4D</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">1B, 2A, 3D, 4C</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">1C, 2D, 3A, 4B</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">1D, 2C, 3B, 4A</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the Following:<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/OBGRDX16102025/2Q.png\"></span></p>",
      "unique_key": "Q324429",
      "question_audio": null,
      "question_video": null,
      "map_id": 324429,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation:</strong></p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/OBGRDX16102025/2E.png\"><p><strong>Reference:</strong><a href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC10455076/\" target=\"_blank\">https://pmc.ncbi.nlm.nih.gov/articles/PMC10455076/</a></p>",
      "correct_choice_id": 12,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate laparoscopic cystectomy</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Observation with follow-up ultrasound in 6-8 weeks</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Oral contraceptive pills to shrink the cyst</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Oophorectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 26-year-old woman presents with mild pelvic pain and irregular menstrual cycles. Transvaginal ultrasound reveals a 4 cm unilocular, thin-walled ovarian cyst with clear fluid and no solid components. She is otherwise asymptomatic with no history of fever or abnormal bleeding. What is the most appropriate management for this patient?</span></p>",
      "unique_key": "Q324430",
      "question_audio": null,
      "question_video": null,
      "map_id": 324430,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation</strong>:</p><p>In <strong>reproductive-age women</strong>, simple <strong>unilocular ovarian cysts &lt;5 cm</strong> are usually <strong>functional cysts</strong> and <strong>asymptomatic</strong>. The recommended management is <strong>expectant</strong>, with <strong>follow-up transvaginal ultrasound</strong> to confirm resolution.</p><ul><li><strong>ACOG guideline:</strong> Repeat imaging at <strong>6-8 weeks</strong> for functional cysts in reproductive-age women.</li><li><strong>RCOG guideline:</strong> For <strong>postmenopausal women</strong>, initial repeat imaging is at <strong>4-6 months</strong> for simple cysts.</li></ul><p><strong>Functional Ovarian Cysts:</strong></p><ul><li>Develop from ovarian follicles during the process of follicular maturation and ovulation.</li><li><strong>Key Features:</strong><ul><li>Usually measure <strong>3-7 cm</strong> in size</li><li>Cysts larger than <strong>10 cm</strong> or persisting beyond <strong>3 months</strong> need evaluation for possible malignancy</li><li>Related to hormonal fluctuations</li><li>Contains clear fluid (may be hemorrhagic in some cases)</li><li>Generally <strong>benign</strong> and often <strong>asymptomatic</strong></li><li>Many resolve spontaneously</li></ul></li><li><strong>Management:</strong><ul><li><strong>Observation: </strong>Most resolve on their own within <strong>4-6 months</strong></li><li><strong>Follow-up: </strong>Ultrasound monitoring at <strong>6-12 weeks</strong> for persistent or growing cysts</li><li><strong>Symptomatic Treatment: </strong>Combined oral contraceptives (COCs) for pain relief or menstrual irregularities</li><li><strong>Surgical Intervention:</strong><ul><li>Indicated for cysts:<ul><li>Larger than <strong>10 cm</strong></li><li>Persistent beyond the expected timeframe</li><li>Causing significant symptoms (e.g., pain, torsion)</li></ul></li></ul></li></ul></li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Immediate laparoscopic cystectomy (Option A):</strong> Invasive and unnecessary for a small, simple, asymptomatic cyst that is likely functional.</p><p><strong>Oral contraceptive pills (Option C):</strong> Not routinely indicated for shrinking functional cysts; they mainly prevent formation of new cysts.</p><p><strong>Oophorectomy (Option D):</strong> Excessive and inappropriate for a simple functional cyst; would unnecessarily remove a healthy ovary.</p>",
      "correct_choice_id": 22,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">B-Lynch uterine compression suture</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Internal iliac artery ligation</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Angiographic embolization</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Total abdominal hysterectomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman experiences severe postpartum hemorrhage post-vaginal delivery. Despite uterotonics and bimanual massage, uterine atony persists. She is being resuscitated. What is the most appropriate surgical intervention?</span></p>",
      "unique_key": "Q324431",
      "question_audio": null,
      "question_video": null,
      "map_id": 324431,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation</strong>:</p><p><strong>B-Lynch uterine compression sutures</strong> are the preferred first surgical step for atonic PPH unresponsive to medical therapy, as they are effective and fertility-sparing.</p><p><strong>Uterine Compression Sutures (B-Lynch and Modifications):</strong></p><ul><li>Uses No. 2 chromic suture to compress anterior and posterior uterine walls.</li><li>Also called \"brace\" sutures due to appearance.</li><li>Primarily indicated for <strong>uterine atony.</strong></li><li>Success rates: variable, 75-99%.<img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/OBGRDX16102025/4E.png\"></li></ul><p><strong>Management of PPH</strong></p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/OBGRDX16102025/4E1.png\"><p><strong>Explanation of other options:</strong></p><p><strong>Internal iliac artery ligation (Option B):</strong> Technically demanding, success rates vary between 50-75%, and not the first surgical choice in acute atonic PPH.</p><p><strong>Angiographic embolization (Option C):</strong> Requires stable patient and interventional radiology setup, not suitable in hemodynamic instability.</p><p><strong>Total abdominal hysterectomy (Option D):</strong> Definitive but last-resort measure, used only when fertility-sparing procedures like compression sutures and ligations fail.</p>",
      "correct_choice_id": 31,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">McRoberts maneuver</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior arm delivery</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Rubin maneuver</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Gaskin maneuver</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 31-year-old woman, G1P0, delivers the fetal head vaginally at term, but the shoulders fail to deliver despite gentle traction, confirming shoulder dystocia. The fetal heart rate is stable, and the patient is in the lithotomy position. What is the most appropriate initial management step for this condition?</span></p>",
      "unique_key": "Q324432",
      "question_audio": null,
      "question_video": null,
      "map_id": 324432,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation:</strong></p><p><strong>McRoberts maneuver</strong> is the first-line management for <strong>shoulder dystocia</strong> as it straightens the sacrum and rotates the symphysis pubis, helping free the impacted anterior shoulder.</p><p><strong>Management of Shoulder Dystocia</strong></p><ol><li><strong> McRoberts Maneuver (Option A)</strong><ul><li><strong>McRoberts maneuver</strong> is the first-line management for shoulder dystocia.</li><li>It involves <strong>rapid</strong> and<strong> maximal flexion</strong> of the maternal hips onto the abdomen, which straightens the sacrum and rotates the symphysis pubis cephalad, decreasing the pelvic angle and facilitating release of the impacted <strong>anterior fetal shoulder.</strong></li><li>Usually combined with <strong>suprapubic pressure</strong>, applied downward and laterally, to reduce the bisacromial diameter and rotate the shoulders from anteroposterior into the oblique pelvic diameter, increasing the chance of shoulder delivery.<img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/OBGRDX16102025/5E.png\"></li></ul></li><li><strong> Posterior Arm Delivery (Option B)</strong><ul><li>Insert hand into posterior pelvis, sweep posterior arm across chest, and deliver.</li><li>Reduces bisacromial diameter and facilitates rotation.</li></ul></li><li><strong> Rotational Maneuvers</strong><ul><li><strong>Rubin maneuver</strong>: hand pushes posterior shoulder toward chest &rarr; abducts shoulders &rarr; rotates into oblique diameter. <strong>(Option C)</strong></li><li><strong>Woods corkscrew maneuver</strong>: hand rotates posterior shoulder 180&deg; &rarr; shoulder girdle rotates &rarr; anterior shoulder freed.</li></ul></li><li><strong> All-Fours (Gaskin) Maneuver (Option D)</strong><ul><li>Patient placed on hands and knees.</li><li>Axial traction helps release posterior shoulder.</li><li>Limited by anesthesia and time for repositioning.</li></ul></li><li><strong> Posterior Axilla Sling Traction</strong><ul><li>Catheter/suction tubing looped under posterior axilla, traction applied upward/outward to deliver posterior arm.</li><li>High success rates.</li></ul></li></ol>",
      "correct_choice_id": 41,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Fetal scalp visible at the introitus without separating the labia</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Fetal skull has reached the pelvic floor</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Fetal head in occipitotransverse position with rotation &le;45 degrees</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Fetal head at or on the perineum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27-year-old primigravida is in the second stage of labor at term. The cervix is fully dilated, and the membranes are ruptured. Which of the following is not a criterion for outlet forceps delivery?</span></p>",
      "unique_key": "Q324433",
      "question_audio": null,
      "question_video": null,
      "map_id": 324433,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation:</strong></p><p><strong>Outlet forceps</strong> can only be applied when the head is in OA or OP position at the perineum, and <strong>not in the occipitotransverse position.</strong></p><p><strong>Criteria for Outlet forceps</strong>:</p><ul><li>Scalp is visible at the introitus without separating the labia. <strong>(Option A)</strong></li><li>Fetal skull has reached the pelvic floor. <strong>(Option B)</strong></li><li>Fetal head is at or on the perineum. <strong>(Option D)</strong></li><li>Fetal head position is occipitoanterior (OA) or occipitoposterior (OP).</li><li>Head is right or left OA/OP but rotation &le; 45 degrees. <strong>(Option C)</strong></li></ul>",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate clamping within 10 seconds of delivery</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Delayed clamping for 30-60 seconds after delivery</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Clamping after 5 minutes or until cord pulsation ceases</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Clamping only after placental delivery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman delivers a healthy term infant vaginally. The infant is breathing spontaneously and has good tone immediately after delivery. What is the most appropriate timing for umbilical cord clamping in this scenario to optimize neonatal outcomes?</span></p>",
      "unique_key": "Q324434",
      "question_audio": null,
      "question_video": null,
      "map_id": 324434,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation:</strong></p><p><strong>Delayed clamping for 30-60 seconds after delivery </strong>allows placental blood transfusion, improving neonatal iron stores and reducing anemia without compromising maternal or neonatal outcomes.</p><p><strong>Cord Clamping</strong></p><ul><li>The umbilical cord is cut between two clamps placed 6-8 cm from the fetal abdomen; a clamp is then applied 2-3 cm from the insertion site.</li><li><strong>Delayed cord clamping (DCC):</strong> Ideally 30-60 seconds for vigorous term neonates to</li><li><strong>Benefits of DCC:</strong> higher neonatal iron stores, lower rates of anemia.</li><li>DCC does <strong>not</strong> worsen Apgar scores, umbilical cord pH, or maternal postpartum hemorrhage.</li><li><strong>Potential risk:</strong> There is a small increase in jaundice requiring phototherapy among term neonates with delayed cord clamping. Overall, the benefits outweigh this risk.</li><li>DCC should be avoided in cases requiring urgent maternal or fetal resuscitation or in abnormal placentation/placental compromise.</li><li><strong>Preterm neonates:</strong> DCC for &ge;30 seconds decreases transfusions and mortality; cord milking may increase risk of severe intraventricular hemorrhage in neonates &lt;32 weeks.</li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Immediate clamping within 10 seconds (Option A):</strong> Prevents placental transfusion, leading to lower neonatal iron stores and higher risk of anemia.</p><p><strong>Clamping after 5 minutes or until cord pulsation ceases (Option C):</strong> Excessively long delay offers minimal additional benefit and may increase the risk of neonatal hyperbilirubinemia.</p><p><strong>Clamping only after placental delivery (Option D):</strong> Timing is inconsistent; may unnecessarily delay resuscitation if needed and does not optimize early neonatal blood volume.</p>",
      "correct_choice_id": 62,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Controlled cord traction shortens the third stage</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxytocin is the first-line uterotonic to prevent PPH</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Uterine massage is a key AMTSL component to reduce PPH</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Early cord clamping is less critical as delayed clamping does not increase PPH risk</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27-year-old primigravida delivers a healthy term infant vaginally. The obstetric team initiates active management of the third stage of labor (AMTSL) to prevent postpartum hemorrhage. Which of the following statements about AMTSL is incorrect?</span></p>",
      "unique_key": "Q324435",
      "question_audio": null,
      "question_video": null,
      "map_id": 324435,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation:</strong></p><p><strong>Uterine massage</strong> may help firm the uterus but is not an essential component of AMTSL for PPH prevention.</p><p><strong>Active Management of the Third Stage of Labor (AMTSL)</strong></p><ul><li>Active intervention to shorten the third stage of labor and reduce postpartum hemorrhage (PPH).</li><li><strong>Key Components:</strong><ul><li><strong>Delayed cord clamping (DCC)</strong> - <strong>does not increase PPH</strong> <strong>(Option D)</strong></li><li><strong>Controlled cord traction</strong> - helps deliver the placenta, reduces manual removal, and shortens third stage, though not proven to prevent hemorrhage. <strong>(Option A)</strong></li><li><strong>Prophylactic uterotonic administration</strong> - most important step to prevent PPH.</li></ul></li><li><strong>Uterotonic Use:</strong><ul><li><strong>Oxytocin (first-line, WHO recommended): (Option B)</strong><ul><li><strong>IM:</strong> 10 units.</li><li><strong>IV infusion:</strong> 20 units/L crystalloid, initial 200-400 mU/min until uterus contracts, then taper.</li></ul></li><li><strong>Methylergometrine:</strong><ul><li>Reduces PPH risk but contraindicated in hypertension.</li><li>Dose 200 &micro;g IM or slow IV.</li></ul></li><li><strong>Misoprostol:</strong><ul><li>Alternative in low-resource settings lacking oxytocin.</li><li>Dose 400-600 &micro;g orally.</li><li>Side effects include fever, diarrhea.</li></ul></li><li><strong>Carbetocin:</strong><ul><li>Long-acting oxytocin analogue, effective but costly.</li><li>Useful where cold-chain storage is difficult.</li></ul></li></ul></li></ul>",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Complete placenta previa</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Nonreassuring fetal status</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Prior classical hysterotomy</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman at term is evaluated for delivery planning. Which of the following is an indication for cesarean section?</span></p>",
      "unique_key": "Q324436",
      "question_audio": null,
      "question_video": null,
      "map_id": 324436,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation:</strong></p><p><strong>Placenta previa, nonreassuring fetal status</strong>, and <strong>prior classical hysterotomy</strong> are established indications for cesarean section.</p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/OBGRDX16102025/9E.png\"><p><strong>Reference</strong>: <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK546707/#:~:text=Common%20indications%20for%20first%2Dtime,.%5B3%5D%5B13%5D\" target=\"_blank\">https://www.ncbi.nlm.nih.gov/books/NBK546707/#</a></p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Head compression</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Umbilical cord compression</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Uteroplacental insufficiency</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Maternal supine hypotension</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 29-year-old primigravida at 39 weeks gestation is in active labor. Electronic fetal monitoring is performed, and an image is shown below. What is the most likely cause of this deceleration pattern?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/OBGRDX16102025/10Q.png\"></span></p>",
      "unique_key": "Q324437",
      "question_audio": null,
      "question_video": null,
      "map_id": 324437,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The graph points to a<strong> late deceleration</strong>. <strong>Late decelerations </strong>show a gradual decrease in FHR that starts at or after the contraction peak and recovers only after the contraction ends. This pattern indicates <strong>uteroplacental insufficiency</strong>, where reduced placental blood flow leads to fetal hypoxia.</p><p><strong>Fetal Heart Rate (FHR) Decelerations</strong></p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/OBGRDX16102025/10E.png\"><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/OBGRDX16102025/10E1.png\">",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Fetal lung fluid secretion</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Fetal urination and swallowing</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Intramembranous flow across fetal vessels</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Transmembranous flow across the amniotic membrane</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old primigravida at 36 weeks gestation undergoes an ultrasound, which shows normal amniotic fluid volume. Which of the following is the primary mechanism for regulating amniotic fluid volume in late pregnancy?</span></p>",
      "unique_key": "Q324438",
      "question_audio": null,
      "question_video": null,
      "map_id": 324438,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Fetal urination</strong> adds fluid and<strong> fetal swallowing</strong> removes it, making these processes the main regulators of amniotic fluid volume in late pregnancy.</p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/OBGRDX16102025/11E.png\">",
      "correct_choice_id": 102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Initiate growth hormone therapy alone</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Begin estrogen therapy with intermittent progesterone</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Schedule immediate ovarian biopsy for follicle harvesting</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Recommend testosterone therapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 14-year-old girl presents with primary amenorrhea. She has short stature, a webbed neck, shield chest, and widely spaced nipples. On examination, pubic and axillary hair are sparse, and her breasts are underdeveloped. Laboratory studies show FSH 50 mIU/mL and estradiol 22 pg/mL. Karyotype reveals 45,X. Which of the following is the most appropriate next step in management?</span></p>",
      "unique_key": "Q324439",
      "question_audio": null,
      "question_video": null,
      "map_id": 324439,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation</strong>:</p><p>This patient has<strong> Turner syndrome</strong> with ovarian failure, indicated by elevated FSH, low estradiol, and 45,X karyotype. The most appropriate next step is to<strong> begin estrogen therapy with intermittent progesterone</strong> to induce secondary sexual characteristics and prevent osteoporosis.</p><p><strong>Turner Syndrome</strong></p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/OBGRDX16102025/12E.png\"><ul><li><strong>Incidence:</strong> 1:2000 to 1:5000 live-born girls</li><li><strong>Chromosomal Pattern:</strong> 45,X (XO) or deletion of short arm of X chromosome; mosaic variants include XO/XX or XO/XY.</li><li><strong>Gonadal Features:</strong><ul><li>Streak gonads: undifferentiated stroma, no sex cells.</li><li>Follicles grow up to 20th week but become atretic; no Grafian follicles &rarr; estrogen deficiency.</li><li>Uterus and vagina present but underdeveloped.</li></ul></li><li><strong>Growth &amp; Stature:</strong> Short stature (not true dwarfism); trunk muscular, short webbed neck, cubitus valgus.</li><li><strong>Sexual Characteristics:</strong><ul><li>Underdeveloped breasts.</li><li>Scanty/absent pubic and axillary hair.</li></ul></li><li><strong>Facial &amp; Skeletal Features:</strong><ul><li>Exaggerated epicanthic folds.</li><li>Shield chest, high-arched palate, low-set ears.</li><li>Lymphedema of extremities at birth.</li><li>Digit deformities.</li></ul></li><li><strong>Cardiovascular Abnormalities:</strong> Coarctation of the aorta may be present.</li><li><strong>Hormonal &amp; Reproductive Management:</strong><ul><li>Primary amenorrhea: FSH &gt;40 mIU/mL, E2 &lt;25 pg/mL &rarr; estrogen therapy with intermittent progesterone to prevent osteoporosis.</li><li>IVF with donor egg possible if uterus is present.</li><li>Some follicles may allow spontaneous menstruation/pregnancy (~15%).</li></ul></li><li><strong>Growth Therapy:</strong> Growth hormone 0.05 mg daily near puberty for 5 years can improve height.</li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Initiate growth hormone therapy alone (Option A):</strong> Growth hormone improves final height but does not address estrogen deficiency, so it will not induce puberty or prevent osteoporosis.</p><p><strong>Schedule immediate ovarian biopsy for follicle harvesting (Option C):</strong> Most Turner patients have streak gonads without functional follicles, making biopsy usually futile.</p><p><strong>Recommend testosterone therapy (Option D):</strong> Turner syndrome patients are genetically female; testosterone is inappropriate and will not induce female secondary sexual characteristics.</p>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal ovarian reserve, suitable for IVF without donor eggs</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Poor ovarian reserve, likely requiring donor egg IVF</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Indicative of polycystic ovary syndrome (PCOD)</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Higher risk of ovarian hyperstimulation syndrome (OHSS)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old woman presents with infertility and irregular menses. Her serum AMH level is measured as 0.8 ng/mL. Which of the following best describes the clinical implication of this AMH level?</span></p>",
      "unique_key": "Q324440",
      "question_audio": null,
      "question_video": null,
      "map_id": 324440,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation</strong>:</p><p>An AMH level &lt;1 ng/mL indicates poor ovarian reserve, reflecting a low number of recruitable follicles. The decision to proceed with donor egg IVF depends on a combination of factors including ovarian reserve, response to stimulation, age, and individual circumstances, rather than AMH alone. Thus, low AMH indicates a higher risk of diminished ovarian response and may require donor egg IVF, but not universally mandated upfront</p><p><strong>Anti-Mullerian Hormone (AMH):</strong></p><ul><li>AMH is a peptide secreted by <strong>Sertoli cells in the testis</strong> and <strong>granulosa cells in the ovary</strong>.</li><li><strong>In males:</strong><ul><li>Secreted from the <strong>7th week of intrauterine life</strong> until puberty.</li><li><strong>Function: </strong>Inhibits the development of the Mullerian system.</li><li>Absence of AMH &rarr; persistent Mullerian structures<strong> &rarr; hermaphroditism.</strong></li></ul></li><li><strong>In females:</strong><ul><li>Secreted by <strong>granulosa cells</strong> after puberty.</li><li>Functions: <strong>Follicular development</strong> and <strong>oocyte maturation</strong>.</li></ul></li><li><strong><strong>Normal serum value</strong></strong><strong>:</strong> 2-6.8 ng/mL. <strong>(Option A)</strong><ul><li>&lt;1 ng/mL <strong>&rarr; poor ovarian reserve. (Option B)</strong></li><li>&gt;10 ng/mL <strong>&rarr; PCOD or </strong><strong>higher OHSS risk</strong> under stimulation<strong>. (Option C &amp; D)</strong></li></ul></li><li>AMH levels are related to:<ul><li>Precocious puberty</li><li>Delayed puberty</li><li>Infertility</li><li>Premature menopause</li></ul></li><li><strong>Clinical utility:</strong><ul><li>Ovarian reserve assessment in infertility and secondary amenorrhea.</li><li>Prognostic marker in <strong>IVF programs</strong>; helps in decision-making for donor egg use.</li></ul></li></ul>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Persistent epigastric pain unresponsive to medication</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Visual disturbances</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Proteinuria &ge;5 g/24 hours</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Systolic blood pressure &ge;160 mmHg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 29-year-old primigravida at 36 weeks gestation with diagnosed preeclampsia presents with new symptoms. Which of the following is not a sign of severe pre-eclampsia?</span></p>",
      "unique_key": "Q324441",
      "question_audio": null,
      "question_video": null,
      "map_id": 324441,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation</strong>:</p> <p><strong>Proteinuria &ge;5 g/24 hours</strong> is no longer used to define <strong>severe preeclampsia.</strong></p> <h3><strong>Signs of Pre-eclampsia</strong></h3> <ul> <li><strong>Severe Hypertension</strong> <ul> <li>Systolic BP &ge; 160 mm Hg <strong>or</strong> diastolic BP &ge; 110 mm Hg <strong>(Option D)</strong></li> <li>On <strong>two occasions at least 4 hours apart</strong>, unless antihypertensive therapy is started sooner</li> </ul> </li> <li><strong>Thrombocytopenia</strong> <ul> <li>Platelet count <strong>&lt; 100,000/mm&sup3; (&times;10&#8313;/L)</strong></li> </ul> </li> <li><strong>Impaired Liver Function</strong> <ul> <li>Liver enzymes <strong>&gt; 2&times; upper limit of normal</strong>, <strong>not due to another cause</strong>, <strong>or</strong></li> <li><strong>Severe, persistent right upper quadrant or epigastric pain</strong> unresponsive to medications <strong>(Option A)</strong></li> </ul> </li> <li><strong>Renal Insufficiency</strong> <ul> <li><strong>Serum creatinine &gt; 1.1 mg/dL</strong> or</li> <li><strong>Doubling of serum creatinine</strong> without other renal disease</li> </ul> </li> <li><strong>Pulmonary Edema</strong></li> <li><strong>New-onset headache</strong> unresponsive to medication and not explained by another cause</li> <li><strong>Visual disturbances</strong> (e.g., blurred vision, scotoma, or temporary blindness) <strong>(Option B)</strong></li> </ul> <p><strong>Reference</strong>:&nbsp;https://www.preeclampsia.org/frontend/assets/img/advocacy_resource/Gestational_Hypertension_and_Preeclampsia_ACOG_Practice_Bulletin,_Number_222_1605448006.pdf</p>",
      "correct_choice_id": 133,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Expectant management with tocolytics</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate cesarean delivery</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Induction of labor with oxytocin</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Administer magnesium sulfate and monitor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 34-year-old multigravida at 35 weeks gestation presents with sudden vaginal bleeding, severe abdominal pain, and a tense uterus. Ultrasound confirms placental abruption with a nonreassuring fetal heart rate pattern. The patient is hemodynamically stable but has significant uterine tenderness. What is the most appropriate management step?</span></p>",
      "unique_key": "Q324442",
      "question_audio": null,
      "question_video": null,
      "map_id": 324442,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation</strong>:</p><p>In <strong>placental abruption</strong> with a viable fetus showing a nonreassuring heart rate, <strong>immediate cesarean delivery</strong> is the treatment of choice to prevent fetal demise.</p><p><strong>Management of Placental Abruption</strong></p><ul><li><strong>Initial step:</strong> Prompt and intensive resuscitation with blood products and crystalloids.</li><li>Fetal status should be confirmed.</li></ul><p><strong>1. Cesarean Delivery</strong></p><ul><li>Indicated when:<ul><li>Fetus is <strong>alive</strong>, viable, and vaginal delivery is <strong>not imminent</strong>.</li><li>Evidence of <strong>fetal compromise</strong>.</li></ul></li><li>Outcomes improve if decision-to-delivery interval &le;20 minutes.</li></ul><p><strong>2. Vaginal Delivery</strong></p><ul><li>Preferred if:<ul><li><strong>Fetus is dead</strong>.</li><li>Fetus is <strong>immature and unlikely to survive</strong> outside the uterus.</li></ul></li><li>Management:<ul><li><strong>Uterotonic agents + uterine massage</strong> &rarr; stimulate myometrial contraction for hemostasis.</li><li>Hemostasis depends mainly on <strong>myometrial contraction</strong>, not maternal coagulation.</li></ul></li></ul><p><strong>3. Expectant Management </strong></p><ul><li>Considered when:<ul><li>Fetus is <strong>preterm and alive</strong>.</li><li>No maternal compromise.</li></ul></li><li>Outcomes:<ul><li>May gain 1-2 weeks of gestation.</li><li>Some cases develop <strong>chronic abruption-oligohydramnios sequence</strong>.</li></ul></li><li>Risks:<ul><li>Sudden worsening &rarr; fetal death possible before intervention.</li><li>Continuous monitoring does not guarantee prevention.</li></ul></li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Expectant management with tocolytics (Option A):</strong> Contraindicated in placental abruption with fetal compromise; delaying delivery increases risk of fetal death and maternal hemorrhage.</p><p><strong>Induction of labor with oxytocin (Option C):</strong> Vaginal delivery is too slow for a compromised fetus; cesarean delivery is safer and faster.</p><p><strong>Administer magnesium sulfate and monitor (Option D):</strong> Magnesium sulfate is used for seizure prophylaxis in preeclampsia, not for managing placental abruption or fetal distress.</p><p><strong>Key Takeaway</strong>:</p><p>In <strong>placental abruption</strong> with a viable but compromised fetus, <strong>immediate cesarean delivery</strong> is the safest management.</p>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Placental lacunae</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Thinning of the retroplacental myometrium</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Disruption of the bladder-uterine serosal interface</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old multigravida with a history of prior cesarean delivery undergoes ultrasound at 32 weeks of gestation to evaluate placental position. Which of the following sonographic findings is suggestive of placenta accreta spectrum (PAS)?</span></p>",
      "unique_key": "Q324443",
      "question_audio": null,
      "question_video": null,
      "map_id": 324443,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation</strong>:</p><p>All listed sonographic features of <strong>placental lacunae, thinning of the retroplacental myometrium,</strong> and <strong>disruption of the bladder-uterine serosal interface</strong> are characteristic findings suggestive of placenta accreta spectrum.</p><p><strong>Ultrasound Criteria for Detection of Placenta Accreta Spectrum (PAS)</strong></p><ul><li><strong>Placental lacunae</strong> - vascular spaces within the placenta, sometimes with prominent colour Doppler flow. <strong>(Option A)</strong></li><li><strong>Thinning/attenuation of the retroplacental myometrium</strong> - myometrial thickness &lt;1 mm, also called <strong>loss of retroplacental clear space</strong>. <strong>(Option B)</strong></li><li><strong>Disruption of the bladder-uterine serosal interface</strong> - irregular, echogenic boundary between bladder and uterine serosa on gray-scale imaging. <strong>(Option C)</strong></li><li><strong>Bridging vessels</strong> - colour Doppler shows vessels coursing from the placenta to the bladder-serosal interface.</li><li><strong>Placental bulge</strong> - placenta pushes outward, distorting uterine or organ contour; may present as a focal exophytic mass in placenta percreta.</li></ul>",
      "correct_choice_id": 154,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, and 3</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">3 and 4</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old primigravida at 12 weeks of gestation undergoes thyroid function testing as part of prenatal care. Which of the following statements about thyroid gland changes in pregnancy are true?<br>1. TRH levels rise significantly to stimulate maternal thyroid activity.<br>2. TSH is elevated in the first trimester due to increased hCG activity.<br>3. TBG doubles due to estrogen-stimulated hepatic synthesis, increasing total T4 and T3.<br>4. Total T4 and T3 levels rise after 6-9 weeks and plateau by 18 weeks.</span></p>",
      "unique_key": "Q324444",
      "question_audio": null,
      "question_video": null,
      "map_id": 324444,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation</strong>:</p><p>The correct statements are <strong>statements 3 and 4.</strong></p><p><strong>Thyroid Gland Changes in Pregnancy</strong></p><ul><li><strong>TRH:</strong> does not rise in pregnancy; crosses placenta &rarr; stimulates fetal pituitary TSH. <strong>(Statement 1)</strong></li><li><strong>TSH:</strong> suppressed in 1st trimester (hCG thyrotropic activity) but within normal range. <strong>(Statement 2)</strong></li><li><strong>Thyroid size:</strong> increases moderately (12 &rarr; 15 mL); any goitre needs evaluation.</li><li><strong>TBG (thyroid-binding globulin):</strong><ul><li>Doubles due to estrogen-stimulated hepatic synthesis + slower metabolism.</li><li>Causes &uarr; total T4 and T3, but <strong>free hormone levels unchanged</strong>. <strong>(Statement 3)</strong></li></ul></li><li><strong>Total T4 and T3:</strong> rise after 6-9 weeks, plateau by 18 weeks. <strong>(Statement 4)</strong></li><li><strong>Free T4:</strong> rises slightly with hCG, normalises later.</li><li>1/3 of women may have relative hypothyroxinemia despite normal TSH.</li></ul>",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Simple hysterectomy</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Radical hysterectomy + PLND</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Chemoradiation</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Modified radical hysterectomy + PLND</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old woman is diagnosed with stage IA2 cervical carcinoma. She has completed her childbearing. What is the most appropriate treatment for her condition?</span></p>",
      "unique_key": "Q324445",
      "question_audio": null,
      "question_video": null,
      "map_id": 324445,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation</strong>:</p><p>For <strong>stage IA2 cervical carcinoma</strong> in a woman who has completed childbearing, <strong>radical hysterectomy with pelvic lymph node dissection</strong> is recommended to ensure complete removal of the tumour and assessment of nodal involvement.</p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/OBGRDX16102025/18E1.png\"><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/OBGRDX16102025/18E2.png\">",
      "correct_choice_id": 174,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Bilateral renal agenesis</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior urethral valves</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Maternal use of ACE inhibitors in the second trimester</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old primigravida at 26 weeks of gestation presents with an ultrasound showing an Amniotic Fluid Index (AFI) of 4 cm and a single deepest pocket of 1.8 cm. Which of the following is a cause of this condition?</span></p>",
      "unique_key": "Q324446",
      "question_audio": null,
      "question_video": null,
      "map_id": 324446,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation</strong>:</p><p><strong>Oligohydramnios </strong>can result from absent fetal urine production (e.g., <strong>bilateral renal agenesis</strong>), obstructed urine outflow (e.g., <strong>posterior urethral valves</strong>), or drug-induced renal dysfunction (e.g., <strong>maternal ACE inhibitor use</strong>).</p><p><strong>Oligohydramnios</strong></p><ul><li>Abnormally decreased amniotic fluid volume.</li><li>Diagnostic criteria:<ul><li><strong>Amniotic Fluid Index (AFI)</strong> &lt; 5 cm.</li><li><strong>Single deepest pocket</strong> &lt; 2 cm.</li></ul></li></ul><p><strong>Etiology</strong></p><ul><li><strong>By gestational age:</strong><ul><li>After 18 weeks &rarr; fetal kidneys are the main contributor.</li><li><strong>Causes of absent urine production:</strong><ul><li>Bilateral renal agenesis. <strong>(Option A)</strong></li><li>Bilateral multicystic dysplastic kidneys.</li><li>Unilateral renal agenesis + contralateral multicystic dysplastic kidney.</li><li>Autosomal recessive polycystic kidney disease (infantile form).</li></ul></li><li><strong>Causes of urinary obstruction:</strong><ul><li>Bladder outlet obstruction (e.g., posterior urethral valves). <strong>(Option B)</strong></li><li>Complex anomalies: persistent cloaca, sirenomelia.</li></ul></li><li><strong>Early (&lt;20-22 weeks):</strong> &rarr; risk of <strong>pulmonary hypoplasia</strong> &rarr; very poor prognosis unless fetal therapy is possible.</li></ul></li><li><strong>Drug-induced:</strong><ul><li>ACE inhibitors &amp; ARBs (2nd/3rd trimester): fetal hypotension &rarr; renal hypoperfusion &rarr; ischemia &rarr; anuric renal failure. <strong>(Option C)</strong></li><li><strong>NSAIDs:</strong><ul><li>Ductus arteriosus constriction.</li><li>Impaired fetal urine production.</li></ul></li><li><strong>Fetal complications:</strong> skull bone hypoplasia, limb contractures.</li></ul></li></ul>",
      "correct_choice_id": 184,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspermia</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Asthenospermia</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Azoospermia</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Teratospermia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old man and his partner present with infertility after 1 year of unprotected intercourse. Semen analysis shows a volume of 3 mL, pH of 7.4, and no sperm observed in the ejaculate after centrifugation, confirmed on two separate samples. What is the most likely diagnosis?</span></p>",
      "unique_key": "Q324447",
      "question_audio": null,
      "question_video": null,
      "map_id": 324447,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000154
      ],
      "solution": "<p><strong>Explanation</strong>:</p><p>The absence of sperm in the ejaculate on repeated semen analysis confirms <strong>azoospermia.</strong></p><p><strong>WHO 2010 vs. 2021 Reference Values for Normal Semen Analysis</strong></p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/OBGRDX16102025/20E.png\"><p><strong>Important Definitions: </strong></p><ul><li><strong>Aspermia:</strong> No semen. <strong>(Option A)</strong></li><li><strong>Azoospermia:</strong> No sperm in semen. <strong>(Option C)</strong></li><li><strong>Oligospermia:</strong> Low sperm count.</li><li><strong>Asthenospermia:</strong> Reduced/absent motility of sperm. <strong>(Option B)</strong></li><li><strong>Necrospermia:</strong> Dead sperm.</li><li><strong>Teratospermia:</strong> Abnormal morphology of sperm. <strong>(Option D)</strong></li></ul><p><strong>Reference:&nbsp;<a href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC8706130/\" target=\"_blank\">https://pmc.ncbi.nlm.nih.gov/articles/PMC8706130/</a></strong></p>",
      "correct_choice_id": 193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}